Abstract: A processor-based device having a plurality of memory cartridges secured within a chassis by a lever system. The processor-based device comprises an indication system to indicate memory system operating conditions. Each memory cartridge has a protective assembly to protect memory elements within the memory cartridge when the memory cartridge is removed from the processor-based device. The processor-based device is operable such that at least one memory cartridge may be removed from the processor-based device without affecting operation of the processor-based device.

Abstract: A processor-based device having a plurality of memory cartridges secured within a chassis by a lever system. The processor-based device comprises an indication system to indicate memory system operating conditions. Each memory cartridge has a protective assembly to protect memory elements within the memory cartridge when the memory cartridge is removed from the processor-based device. The processor-based device is operable such that at least one memory cartridge may be removed from the processor-based device without affecting operation of the processor-based device.

Abstract: This invention provides a method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal blood circulation which comprises contacting the extracorporeal circulating blood with a Factor IXa compound in an amount effective to inhibit thrombosis in the blood of a patient and under conditions such that the Factor IXa compound circulates in the patient. The Factor IXa compound may include an active site-blocked Factor IXa compound or Glu-Gly-Arg chloromethyl ketone-inactivated human factor IXa compound. This invention also provides that the effective amount may be from about 0.1 &mgr;g/ml plasma to about 250 &mgr;g/ml plasma or from about 0.5 &mgr;g/ml plasma to about 25 &mgr;g/ml plasma. The patient may be subjected to extracorporeal blood circulation during transplant surgery or cardiopulmonary bypass surgery.

Abstract: A method of replacing a memory module in a computer system. Specifically, a method for replacing a memory module in a segment of a redundant memory system, without powering-down the memory system.

Abstract: A method of adding memory capacity to a computer system. The computer system comprises a redundant memory system including a plurality of memory cartridges. By powering-down a memory cartridge, adding an additional memory module to the memory cartridge, and powering-up the memory cartridge for each memory cartridge in the system, the system can transition from a redundant mode of operation to a non-redundant mode of operation for each power-down, thus allowing the computer system to remain functional during the addition of the memory module. Alternatively, memory cartridges with higher memory capacity than those currently present in the computer system can be used to replace existing memory cartridges in the computer system, using the same techniques.

Abstract: A processor-based device having a plurality of memory cartridges secured within a chassis by a lever system. The processor-based device comprises an indication system to indicate memory system operating conditions. Each memory cartridge has a protective assembly to protect memory elements within the memory cartridge when the memory cartridge is removed from the processor-based device. The processor-based device is operable such that at least one memory cartridge may be removed from the processor-based device without affecting operation of the processor-based device.

Abstract: Systems, apparatus and methods for a voice activated delivery of orders to the restaurant food preparers. Food orders from customers are entered in a point-of-sale (POS) register. The restaurant worker speaks an order which is received by a speech-to-text search, resulting in a conversion into speech of a POS entry. The restaurant worker receives an audible synthesized voice reciting the POS entry. As a result, the restaurant worker is not required to view a visual display. The preferred embodiments include wireless communication with the restaurant worker so that the worker may move freely while speaking voice commands and receiving the synthesized voice orders.

Abstract: The control logic for a hot-pluggable memory cartridge for use in a redundant memory system. To implement a hot-pluggable memory cartridge in a redundant memory system, control logic to control the sequence of events for powering-up and powering-down a memory cartridge is provided.

Abstract: The present invention provides for a method for treating an ischemic disorder in a subject which comprises administering to the subject a pharmaceutically acceptable Factor IXa compound in a sufficient amount over a sufficient time period so as to treat the ischemic disorder in the subject. The invention further provides a method for treating an ischemic disorder in a subject which comprises administering to the subject a pharmaceutically acceptable form of inactivated Factor IXa in a sufficient amount over a sufficient period of time to inhibit coagulation so as to treat the ischemic disorder in the subject.

Abstract: The present invention provides for a method of treating an ischemic disorder in a subject which comprises administering to the subject a pharmaceutically acceptable form of inactivated Factor IX in a sufficient amount over a sufficient period of time to inhibit coagulation so as to treat the ischemic disorder in the subject.

Abstract: A fluid actuator for use in a fluid injector assembly including a piston arranged for reciprocation in a chamber, the piston including a connected plunger operating in an injection chamber. A control valve member is actuated to apply fluid to the chamber on opposite sides of the piston to reciprocate the piston and plunger. A fluid throttling arrangement is provided to decelerate the piston towards the ends of its stroke. The fluid actuator may also be associated with an engine valve assembly.

Abstract: This invention provides an assay to monitor antithrombic activity of a Factor IXa compound infused into circulation of a patient which includes: (a) obtaining Factor IXa-deficient plasma; (b) mixing the plasma from step (a) with diatomaceous and with plasma from the patient; (c) incubating the mixture with a source of lipid and calcium chloride under conditions suitable for clot formation; and (d) measuring time necessary for clot formation in the incubate, thereby monitoring the antithrombic activity of the Factor IXa compound infused into the circulation of the patient.

Abstract: A fluid actuator for use in a fluid injector assembly including a piston arranged for reciprocation in a chamber, the piston including a connected plunger operating in an injection chamber. A control valve member is actuated to apply fluid to the chamber on opposite sides of the piston to reciprocate the piston and plunger. A fluid throttling arrangement is provided to decelerate the piston towards the ends of its stroke. The fluid actuator may also be associated with an engine valve assembly. A fluid actuated engine piston assembly is also described.

Abstract: This invention concerns a method of preparing a cryoprecipitated suspension containing fibrinogen and Factor XIII useful as a precursor in the preparation of a fibrin glue which involves (a) freezing fresh frozen plasma from a single donor such as a human or other animal, e.g., a cow, sheep or pig, which has been screened for blood transmitted diseases, e.g., one or more of syphilis, hepatitis or acquired immune deficiency syndrome at about -80.degree. C. for at least 6 hours, preferably for at least about 12 hours; (b) raising the temperature, so as to form a supernatant and a cryoprecipitated suspension containing fibrinogen and Factor XIII; and (c) recovering the cryopricipitated suspension.

Abstract: This invention concerns a method of preparing a cryoprecipitated suspension containing fibrinogen and Factor XIII useful as a precursor in the preparation of a fibrin glue which involves (a) freezing fresh frozen plasma from a single donor such as a human or other animal, e.g. a cow, sheep or pig, which has been screened for blood transmitted diseases, e.g. one or more of syphilis, hepatitis or acquired immune deficiency syndrome at about =80.degree. C. for at least about 6 hours, preferably for at least about 12 hours; (b) raising the temperature of the frozen plasma, e.g. to between about 0.degree. C. and room temperature, so as to form a supernatant and a cryoprecipitated suspension containing fibrinogen and Factor XIII; and (c) recovering the cryoprecipitated suspension.